ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 226,81
-0,93%
Dow Jones
42 342,24
0,00%
DAX
19 744,11
-1,28%
Brent Oil
72,19
-0,27%
Bitcoin
94 946,03
-2,60%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Nuvalent Inc (NUVL) Cours

Nuvalent Inc

Nuvalent Inc (NUVL)

NASDAQ
84,64
1,19
(1,43%)
Fermé 20 Décembre 10:00PM
Retardé de 15 minutes
83,80
-0,84
( -0,99% )
Avant marché: 2:37PM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
83,80
Prix Achat
83,00
Prix Vente
88,45
Volume échangé
942
0,00 Fourchette du Jour 0,00
61,795 Plage de 52 semaines 113,51
Cap du marché
5,954B
Clôture Veille
84,64
Ouverture
-
Dernière Transaction
100
@
83.8
(formt)
Dernière heure de transaction
14:27:30
Volume financier
-
VWAP
-
Volume moyen (3 m)
420 890
Actions en circulation
71 052 559
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-47,65
Bénéfice par action (BPA)
-1,78
Chiffre d'affairess
-
Bénéfice net
-126,22M

À propos de Nuvalent Inc

Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets. Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets.

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.nuvalent.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Nuvalent Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker NUVL. Le dernier cours de clôture d'Nuvalent était de US$84,64. Au cours de la dernière année, les actions de Nuvalent ont été négociées dans une fourchette de prix de US$ 61,795 à US$ 113,51.

Nuvalent compte actuellement 71 052 559 actions en circulation. La capitalisation boursière d'Nuvalent est de US$6,01 milliard. Nuvalent a un ratio cours/bénéfice (ratio PE) de -47.65.

NUVL Dernières nouvelles

Plus de nouvelles

Nuvalent to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nuvalent to Present at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire CAMBRIDGE, Mass., Dec. 19, 2024 CAMBRIDGE, Mass., Dec. 19, 2024 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL...

19 Décembre 2024
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

18 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

18 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

18 Décembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

09 Décembre 2024
Edgar (US Regulatory)

Nuvalent Appoints Grant Bogle to Board of Directors

Nuvalent Appoints Grant Bogle to Board of Directors PR Newswire CAMBRIDGE, Mass., Dec. 9, 2024 CAMBRIDGE, Mass., Dec. 9, 2024 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage...

09 Décembre 2024
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

03 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

27 Novembre 2024
Edgar (US Regulatory)

Nuvalent to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nuvalent to Participate in the Piper Sandler 36th Annual Healthcare Conference PR Newswire CAMBRIDGE, Mass, Nov. 26, 2024 CAMBRIDGE, Mass, Nov. 26, 2024 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq:...

26 Novembre 2024
PR Newswire (US)

Form 144 - Report of proposed sale of securities

25 Novembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-2.19-2.5468077683585.9989.30580.9659316986.16411818CS
4-8.6815-9.3872828619892.481597.6580.9639351690.36365702CS
12-17.96-17.6493710692101.76106.3280.9642089093.74783469CS
265.97.5738125802377.9113.5164.6744040890.81698534CS
529.7313.136222492274.07113.5161.79543438082.92467086CS
15661.59277.30751913622.21113.517.0935140656.81440951CS
26065.7362.98342541418.1113.517.0932933955.14988087CS

NUVL - Frequently Asked Questions (FAQ)

What is the current Nuvalent share price?
The current share price of Nuvalent is US$ 83,80
How many Nuvalent shares are in issue?
Nuvalent has 71 052 559 shares in issue
What is the market cap of Nuvalent?
The market capitalisation of Nuvalent is USD 6,01B
What is the 1 year trading range for Nuvalent share price?
Nuvalent has traded in the range of US$ 61,795 to US$ 113,51 during the past year
What is the PE ratio of Nuvalent?
The price to earnings ratio of Nuvalent is -47,65
What is the reporting currency for Nuvalent?
Nuvalent reports financial results in USD
What is the latest annual profit for Nuvalent?
The latest annual profit of Nuvalent is USD -126,22M
What is the registered address of Nuvalent?
The registered address for Nuvalent is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Nuvalent website address?
The website address for Nuvalent is www.nuvalent.com
Which industry sector does Nuvalent operate in?
Nuvalent operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MYSZMy Size Inc
US$ 6,15
(355,56%)
41,48M
LYTLytus Technologies Holdings PTV Ltd
US$ 2,85
(183,58%)
20,13M
HSDTHelius Medical Technologies Inc
US$ 1,03
(114,58%)
48,8M
TAOPTaoping Inc BVI
US$ 0,56
(76,66%)
47,29M
HUMAHumacyte Inc
US$ 5,9399
(71,67%)
14,42M
CYNCYNGN Inc
US$ 0,75
(-53,42%)
606,72k
MTEMMolecular Templates Inc
US$ 0,178
(-49,14%)
940,77k
PRFXPainReform Ltd
US$ 7,12
(-36,20%)
438,96k
GALTGalectin Therapeutics Inc
US$ 1,28
(-36,00%)
1,29M
HYZNHyzon Motors Inc
US$ 1,0902
(-34,33%)
79,05k
HSDTHelius Medical Technologies Inc
US$ 1,0401
(116,69%)
48,81M
TAOPTaoping Inc BVI
US$ 0,5517
(74,04%)
47,29M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
42,77M
MYSZMy Size Inc
US$ 6,23
(361,48%)
41,53M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,578
(1,40%)
26,96M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
NUVL
Nuvalent
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés